NaviFUS Corp. logo

NaviFUS Corp. (6872)

Market Closed
11 Aug, 05:30
TWSE TWSE
NT$
15. 80
-0.2
-1.25%
NT$
1.83B Market Cap
- P/E Ratio
- Div Yield
31,218 Volume
- Eps
NT$ 16
Previous Close
Add Transaction
Day Range
15.3 15.8
Year Range
15 23.95
Want to track 6872 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

6872 closed today lower at NT$15.8, a decrease of -1.25% from yesterday's close, completing a monthly decrease of -7.0588% or -NT$1.2. Over the past 12 months, 6872 stock lost -21.393%.
6872 is not paying dividends to its shareholders.
NaviFUS Corp. has completed 2 stock splits, with the recent split occurring on Jan 23, 2024.
The company's stock is traded on one exchange.

6872 Chart

People also search for

Chunghwa Chemical Synthesis & Biotech Co., Ltd.
NT$ 36.1
-1.3661%
Chang Type Industrial Co., Ltd.
NT$ 21.5
-2.0501%
Sheh Fung Screws Co., Ltd.
NT$ 37.5
+6.383%
Taiwan Name Plate Co., Ltd.
NT$ 32.45
0%
Sinher Technology Inc.
NT$ 18.95
-1.8135%

NaviFUS Corp. (6872) FAQ

What is the stock price today?

The current price is NT$15.80.

On which exchange is it traded?

NaviFUS Corp. is listed on TWSE.

What is its stock symbol?

The ticker symbol is 6872.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 1.83B.

Has NaviFUS Corp. ever had a stock split?

NaviFUS Corp. had 2 splits and the recent split was on Jan 23, 2024.

NaviFUS Corp. Profile

Biotechnology Industry
Healthcare Sector
- CEO
TWSE Exchange
TW0006872005 ISIN
Taiwan Country
- Employees
- Last Dividend
23 Jan 2024 Last Split
- IPO Date

Overview

NaviFUS Corp. is a pioneering medical device company based in Taipei, Taiwan, focusing on the development and commercialization of focused ultrasound (FUS) solutions tailored for unmet needs within the realm of neuromedicine. Since its inception in 2015, NaviFUS Corp. has dedicated itself to advancing medical technology, specifically through the innovative application of FUS systems, to address various neurological conditions. The company's commitment to enhancing patient care and outcomes is evident in its pursuit of creating cutting-edge solutions that facilitate targeted treatments and interventions in the brain with high precision and minimal invasiveness.

Products and Services

  • NaviFUS

    The flagship product of NaviFUS Corp., NaviFUS, is a state-of-the-art neuronavigator-guided transcranial Focused Ultrasound (FUS) system. It is ingeniously designed to deliver focal energy with precision into deep brain tissues. This innovative approach allows for non-invasive treatments targeting specific brain areas, with potential applications spanning from targeted drug delivery and neuromodulation to immuno-stimulation. Its versatility and precision make it a groundbreaking tool in the treatment and management of neurological conditions.

  • NAVIRFA

    NAVIRFA represents another significant technological advancement from NaviFUS Corp., incorporating a sophisticated optical 3D surgical tracking mechanism. This navigation system is crucial for ultrasonic interventional procedures, particularly in monitoring the 3D position of the needle tip throughout the process. It enhances the accuracy, safety, and effectiveness of FUS-based interventions, thereby optimizing patient outcomes in various therapeutic contexts.

Contact Information

Address: No. 246, Chengde Rd.
Phone: 886 2 2586 0560